Carotid Artery Stenting for Stroke Prevention

Canadian Journal of Cardiology

Volumn 30, Issue 1, 2014, Pages 22-34

  Saw, Jacqueline ^a  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CAROTID ANGIOPLASTY; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY STENTING; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; EMBOLIC PROTECTION FILTER; HUMAN; PATIENT SAFETY; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVASCULARIZATION; REVIEW; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 84890818747     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2013.09.030     Document Type: Review

References (75)

1. Public Health Agency of Canada. Tracking Heart Disease and Stroke in Canada-Stroke Highlights 2011. Available at: Accessed October 27,2013. http://www.phac-aspc.gc.ca/cd-mc/cvd-mcv/sh-fs-2011/index-eng.php.
2. Go A.S., Mozaffarian D., Roger V.L., et al. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013, 127:e6-245.
3. Heart and Stroke Foundation. Statistics. Available at: Accessed October 27,2013. http://www.heartandstroke.com/site/c.ikIQLcMWJtE/b.3483991/k.34A8/Statistics.htm.
4. Hill A. Should patients be screened for asymptomatic carotid artery stenosis?. Can J Surg 1998, 41:208-213.
5. Eslami M.H., McPhee J.T., Simons J.P., Schanzer A., Messina L.M. National trends in utilization and postprocedure outcomes for carotid artery revascularization 2005 to 2007. JVasc Surg 2011, 53:307-315.
6. Eastcott H., Pickering G., Rob C. Reconstruction of internal carotid artery in a patient with intermittent attacks of hemiplegia. Lancet 1954, 267:994-996.
7. Dumont T.M., Rughani A.I. National trends in carotid artery revascularization surgery. JNeurosurg 2012, 116:1251-1257.
8. Mayberg M.R., Wilson S.E., Yatsu F., et al. Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis. Veterans Affairs Cooperative Studies Program 309 Trialist Group. JAMA 1991, 266:3289-3294.
9. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. NEngl J Med 1991, 325:445-453. North American Symptomatic Carotid Endarterectomy Trial Collaborators.
10. Barnett H.J., Taylor D.W., Eliasziw M., et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. NEngl J Med 1998, 339:1415-1425.
11. Randomized trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998, 351:1379-1387.
12. Hobson R.W., Weiss D.G., Fields W.S., et al. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. The Veterans Affairs Cooperative Study Group. NEngl J Med 1993, 328:221-227.
13. Endarterectomy for asymptomatic carotid artery stenosis Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 1995, 273:1421-1428.
14. Halliday A., Mansfield A., Marro J., et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 2004, 363:1491-1502.
15. Furie K.L., Kasner S.E., Adams R.J., et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011, 42:227-276.
16. Kerber C.W., Cromwell L.D., Loehden O.L. Catheter dilatation of proximal carotid stenosis during distal bifurcation endarterectomy. AJNR Am J Neuroradiol 1980, 1:348-349.
17. Timaran C.H., Rosero E.B., Higuera A., et al. Randomized clinical trial of open-cell vs closed-cell stents for carotid stenting and effects of stent design on cerebral embolization. JVasc Surg 2011, 54. 1310-6.e1. discussion 1316.
18. Angelini A., Reimers B., Della Barbera M., et al. Cerebral protection during carotid artery stenting: collection and histopathologic analysis of embolized debris. Stroke 2002, 33:456-461.
19. Mathur A., Roubin G.S., Iyer S.S., et al. Predictors of stroke complicating carotid artery stenting. Circulation 1998, 97:1239-1245.
20. Ohki T., Marin M.L., Lyon R.T., et al. Exvivo human carotid artery bifurcation stenting: correlation of lesion characteristics with embolic potential. JVasc Surg 1998, 27:463-471.
21. Reimers B., Corvaja N., Moshiri S., et al. Cerebral protection with filter devices during carotid artery stenting. Circulation 2001, 104:12-15.
22. Cloft H.J. Distal protection: maybe less than you think. AJNR Am J Neuroradiol 2008, 29:407-408.
23. Kastrup A., Groschel K., Nagele T., et al. Effects of age and symptom status on silent ischemic lesions after carotid stenting with and without the use of distal filter devices. AJNR Am J Neuroradiol 2008, 29:608-612.
24. Almekhlafi M.A., Demchuk A.M., Mishra S., et al. Malignant emboli on transcranial Doppler during carotid stenting predict postprocedure diffusion-weighted imaging lesions. Stroke 2013, 44:1317-1322.
25. Theron J., Courtheoux P., Alachkar F., Bouvard G., Maiza D. New triple coaxial catheter system for carotid angioplasty with cerebral protection. AJNR Am J Neuroradiol 1990, 11:869-874. discussion 875-7.
26. Loghmanpour N.A., Siewiorek G.M., Wanamaker K.M., et al. Assessing the impact of distal protection filter design characteristics on 30-day outcomes of carotid artery stenting procedures. JVasc Surg 2013, 57. 309-17.e2.
27. Gray W.A., Hopkins L.N., Yadav S., et al. Protected carotid stenting in high-surgical-risk patients: the ARCHeR results. JVasc Surg 2006, 44:258-268.
28. White C.J., Iyer S.S., Hopkins L.N., Katzen B.T., Russell M.E. Carotid stenting with distal protection in high surgical risk patients: the BEACH trial 30 day results. Catheter Cardiovasc Interv 2006, 67:503-512.
29. Hopkins L.N., Myla S.V., Grube E., et al. Carotid artery revascularisation in high-surgical-risk patients with the NexStent and the FilterWire EX/EZ: 3-year results from the CABERNET trial. EuroIntervention 2010, 5:917-924.
30. Safian R.D., Bresnahan J.F., Jaff M.R., et al. Protected carotid stenting in high-risk patients with severe carotid artery stenosis. JAm Coll Cardiol 2006, 47:2384-2389.
31. Clair D.G., Hopkins L.N., Mehta M., et al. Neuroprotection during carotid artery stenting using the GORE flow reversal system: 30-day outcomes in the EMPiRE Clinical Study. Catheter Cardiovasc Interv 2011, 77:420-429.
32. Myla S., Bacharach J.M., Ansel G.M., et al. Carotid artery stenting in high surgical risk patients using the FiberNet embolic protection system: the EPIC trial results. Catheter Cardiovasc Interv 2010, 75:817-822.
33. Higashida R.T., Popma J.J., Apruzzese P., Zimetbaum P. Evaluation of the medtronic exponent self-expanding carotid stent system with the medtronic guardwire temporary occlusion and aspiration system in the treatment of carotid stenosis: combined from the MAVErIC (Medtronic AVE Self-expanding CaRotid Stent System with distal protection in the Treatment of Carotid stenosis) I and MAVErIC II trials. Stroke 2010, 41:e102-e109.
34. Hill M.D., Morrish W., Soulez G., et al. Multicenter evaluation of a self-expanding carotid stent system with distal protection in the treatment of carotid stenosis. AJNR Am J Neuroradiol 2006, 27:759-765.
35. Reimers B., Sievert H., Schuler G.C., et al. Proximal endovascular flow blockage for cerebral protection during carotid artery stenting: results from a prospective multicenter registry. JEndovasc Ther 2005, 12:156-165.
36. Endovascular Today CAS clinical trial and registry update. Endovascr Today 2007, 6:76-79.
37. Coppi G., Moratto R., Silingardi R., et al. PRIAMUS-proximal flow blockage cerebral protectIon during carotid stenting: results from a multicenter Italian registry. JCardiovasc Surg (Torino) 2005, 46:219-227.
38. Matsumura J.S., Gray W., Chaturvedi S., et al. Results of carotid artery stenting with distal embolic protection with improved systems: Protected Carotid Artery Stenting in Patients at High Risk for Carotid Endarterectomy (PROTECT) trial. JVasc Surg 2012, 55. 968-76.e5.
39. Ansel G.M., Hopkins L.N., Jaff M.R., et al. Safety and effectiveness of the INVATEC MO.MA proximal cerebral protection device during carotid artery stenting: results from the ARMOUR pivotal trial. Catheter Cardiovasc Interv 2010, 76:1-8.
40. Gray W.A., Yadav J.S., Verta P., et al. The CAPTURE registry: results of carotid stenting with embolic protection in the post approval setting. Catheter Cardiovasc Interv 2007, 69:341-348.
41. Gray W.A., Rosenfield K.A., Jaff M.R., et al. Influence of site and operator characteristics on carotid artery stent outcomes: analysis of the CAPTURE 2 (Carotid ACCULINK/ACCUNET Post Approval Trial to Uncover Rare Events) clinical study. JACC Cardiovasc Interv 2011, 4:235-246.
42. Katzen B.T., Criado F.J., Ramee S.R., et al. Carotid artery stenting with emboli protection surveillance study: thirty-day results of the CASES-PMS study. Catheter Cardiovasc Interv 2007, 70:316-323.
43. Gray W.A., Chaturvedi S., Verta P. Thirty-day outcomes for carotid artery stenting in 6320 patients from 2 prospective, multicenter, high-surgical-risk registries. Circ Cardiovasc Interv 2009, 2:159-166.
44. Metzger C., Hibbard R., Ashchi M., et al. Peri-procedural outcomes after carotid artery stenting with the first 15,000 patients enrolled in the SAPPHIRE Worldwide Study. JAm Coll Cardiol 2012, 60.
45. Blackshear J.L., Cutlip D.E., Roubin G.S., et al. Myocardial infarction after carotid stenting and endarterectomy: results from the carotid revascularization endarterectomy vs stenting trial. Circulation 2011, 123:2571-2578.
46. Yadav J.S., Wholey M.H., Kuntz R.E., et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. NEngl J Med 2004, 351:1493-1501.
47. Gurm H.S., Yadav J.S., Fayad P., et al. Long-term results of carotid stenting versus endarterectomy in high-risk patients. NEngl J Med 2008, 358:1572-1579.
48. Mas J.L., Chatellier G., Beyssen B., et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. NEngl J Med 2006, 355:1660-1671.
49. Ringleb P.A., Allenberg J., Bruckmann H., et al. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet 2006, 368:1239-1247.
50. Eckstein H.H., Ringleb P., Allenberg J.R., et al. Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial. Lancet Neurol 2008, 7:893-902.
51. Brott TG, Hobson RW 2nd, Howard G, etal. Stenting vs endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 2010;363:11-23.
52. Grant A., White C., Ansel G., et al. Safety and efficacy of carotid stenting in the very elderly. Catheter Cardiovasc Interv 2010, 75:651-655.
53. Setacci C., de Donato G., Chisci E., et al. Is carotid artery stenting in octogenarians really dangerous?. JEndovasc Ther 2006, 13:302-309.
54. Ederle J., Dobson J., Featherstone R.L., et al. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial. Lancet 2010, 375:985-997.
55. Bonati L.H., Jongen L.M., Haller S., et al. New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the International Carotid Stenting Study (ICSS). Lancet Neurol 2010, 9:353-362.
56. Altinbas A., van Zandvoort M.J., van den Berg E., et al. Cognition after carotid endarterectomy or stenting: a randomized comparison. Neurology 2011, 77:1084-1090.
57. Bijuklic K., Wandler A., Tubler T., Schofer J. Impact of asymptomatic cerebral lesions in diffusion-weighted magnetic resonance imaging after carotid artery stenting. JACC Cardiovasc Interv 2013, 6:394-398.
58. Montorsi P., Caputi L., Galli S., et al. Microembolization during carotid artery stenting in patients with high-risk, lipid-rich plaque. A randomized trial of proximal vs distal cerebral protection. JAm Coll Cardiol 2011, 58:1656-1663.
59. Stabile E., Salemme L., Sorropago G., et al. Proximal endovascular occlusion for carotid artery stenting: results from a prospective registry of 1,300 patients. JAm Coll Cardiol 2010, 55:1661-1667.
60. Nikas D., Reith W., Schmidt A., et al. Prospective, multicenter European study of the GORE flow reversal system for providing neuroprotection during carotid artery stenting. Catheter Cardiovasc Interv 2012, 80:1060-1068.
61. Stabile E., Garg P., Cremonesi A., et al. European Registry of Carotid Artery Stenting: results from a prospective registry of eight high volume EUROPEAN institutions. Catheter Cardiovasc Interv 2012, 80:329-334.
62. Bersin R.M., Stabile E., Ansel G.M., et al. Ameta-analysis of proximal occlusion device outcomes in carotid artery stenting. Catheter Cardiovasc Interv 2012, 80:1072-1078.
63. Pinter L., Ribo M., Loh C., et al. Safety and feasibility of a novel transcervical access neuroprotection system for carotid artery stenting in the PROOF Study. JVasc Surg 2011, 54:1317-1323.
64. Raman G., Moorthy D., Hadar N., et al. Management strategies for asymptomatic carotid stenosis: a systematic review and meta-analysis. Ann Intern Med 2013, 158:676-685.
65. Lin P.H., Bush R.L., Peden E.K., et al. Carotid artery stenting with neuroprotection: assessing the learning curve and treatment outcome. Am J Surg 2005, 190:850-857.
66. Hopkins L.N., Roubin G.S., Chakhtoura E.Y., et al. The Carotid Revascularization Endarterectomy vs. Stenting Trial: credentialing of interventionalists and final results of lead-in phase. JStroke Cerebrovasc Dis 2010, 19:153-162.
67. Bates E.R., Babb J.D., Casey D.E., et al. ACCF/SCAI/SVMB/SIR/ASITN 2007 clinical expert consensus document on carotid stenting: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting). JAm Coll Cardiol 2007, 49:126-170.
68. Canadian Stroke Network/Heart and Stroke Foundation of Canada. Canadian Stroke Best Practices and Standards Working Group. Canadian Best Practice Recommendations for Stroke Care. Fourth Edition. September 2012. Available at: Accessed October 27,2013. http://www.strokebestpractices.ca/wp-content/uploads/2012/10/20120BPR_Ch2_Prevention_Final-Version_20Sept-2012F-12.pdf.
69. Macdonald S., Lee R., Williams R., Stansby G. Towards safer carotid artery stenting: a scoring system for anatomic suitability. Stroke 2009, 40:1698-1703.
70. Setacci C., Chisci E., Setacci F., et al. Siena carotid artery stenting score: a risk modelling study for individual patients. Stroke 2010, 41:1259-1265.
71. Faggioli G.L., Ferri M., Feyrie A., et al. Aortic arch anomalies are associated with increased risk of neurological events in carotid stent procedures. Eur J Vasc Endovasc Surg 2007, 33:436-441.
72. Faggioli G., Ferri M., Rapezzi C., et al. Atherosclerotic aortic lesions increase the risk of cerebral embolism during carotid stenting in patients with complex aortic arch anatomy. JVasc Surg 2009, 49:80-85.
73. Sternbergh W.C., Crenshaw G.D., Bazan H.A., Smith T.A. Carotid endarterectomy is more cost-effective than carotid artery stenting. JVasc Surg 2012, 55:1623-1628.
74. Mahoney E.M., Greenberg D., Lavelle T.A., et al. Costs and cost-effectiveness of carotid stenting vs endarterectomy for patients at increased surgical risk: results from the SAPPHIRE trial. Catheter Cardiovasc Interv 2011, 77:463-472.
75. Almekhlafi MA, Hill MD, Wiebe S, etal. When is carotid angioplasty and stenting the cost-effective alternative for revascularization of symptomatic carotid stenosis? A Canadian Health System perspective [e-pub ahead of print]. AJNR Am J Neuroradiol, accessed October 27,2013.